biotech

Funding drought: how can biotech and biopharma keep trials running?
Clinical Trials Arena
Thu, 03/20/25 - 11:12 am
funding
biotech
clinical trials
The key factors shaping China’s biopharma boom
Pharma Voice
Thu, 03/20/25 - 09:57 am
China
biotech
tariffs
regulatory
CAR-T
How non-traditional investors fuel up-and-coming biotechs when VC funding dries up
Pharma Voice
Tue, 03/18/25 - 11:23 am
R&D
biotech
funding
Bluebird’s go-private deal highlights fraught life preserver for struggling biotechs
BioSpace
Wed, 03/12/25 - 11:19 am
Bluebird Bio
funding
biotech
restructuring
[podcast]What to expect from the biotech IPO market in 2025
Fierce Biotech
Fri, 01/31/25 - 11:18 am
biotech
IPOs
JPMHC 2025
Metsera, Maze secure combined $415 million in IPOs
BioPharma Dive
Fri, 01/31/25 - 11:05 am
Metsera
Maze Therapeutics
IPOs
biotech
Executive hiring changes reflect a broader biotech comeback
Pharma Voice
Thu, 01/30/25 - 10:49 am
biotech
executives
The biopharma industry outlook on 2025: Uncertainty and change
BioPharma Dive
Sun, 01/26/25 - 04:16 pm
biotech
JPMHC 2025
China
regulatory
Donald Trump
‘A really rational IPO environment’: What does it takes for a biotech to go public now?
Fierce Biotech
Fri, 01/24/25 - 11:44 am
biotech
IPOs
Septerna
Sofinnova
Rapport Therapeutics
Biopharma’s AI rally: Readiness not hype in 2025
Pharmaphorum
Thu, 01/16/25 - 11:01 am
biotech
artificial intelligence
5 questions facing emerging biotech in 2025
BioPharma Dive
Tue, 01/14/25 - 11:22 am
biotech
funding
China
IPOs
cell therapy
gene therapy
M&A
Big Pharma layoff rounds jump 281% in '24, but overall industry rates similar to '23
Fierce Biotech
Mon, 01/6/25 - 10:58 am
layoffs
biotech
Pfizer
JNJ
Bristol Myers Squibb
Roivant
3 closely watched drugs that failed in the clinic
Pharma Voice
Mon, 12/16/24 - 11:24 am
biotech
Roche
tiragolumab
AbbVie
emraclidine
Cassava Sciences
simufilam
Jury convicts ex-CytoDyn CEO on 9 counts tied to biotech fraud
Fierce Biotech
Wed, 12/11/24 - 11:02 am
legal
CytoDyn
biotech
fraud
Maryland
What can we learn from 2024’s biotech IPOs?
Fierce Biotech
Fri, 12/6/24 - 09:25 am
biotech
IPOs
Atlas doubles down on ‘disciplined’ biotech investing with latest fundraise
BioPharma Dive
Thu, 12/5/24 - 04:11 pm
Atlas Ventures
funding
biotech
An RNA biotech draws the blueprint for a late-stage Dravet syndrome trial and beyond
Pharma Voice
Tue, 11/26/24 - 09:45 am
Stoke Therapeutics
biotech
RNA
Dravet syndrome
Biotechs go big for bitcoin: Trio of companies each plan to stash $1M as reserve
Fierce Biotech
Wed, 11/20/24 - 11:32 am
Bitcoin
cryptocurrency
Donald Trump
biotech
Acurx Pharmaceuticals
Hoth Therapeutics
Where are they now? 4 biotechs that soared then crashed during the pandemic
Pharma Voice
Fri, 11/15/24 - 11:06 am
biotech
pandemic
COVID-19
CureVac
Novavax
Inovio
Veru
Syncona aims Slingshot at biotech's 'translational gap'
Pharmaphorum
Thu, 11/14/24 - 10:05 am
Syncona
UK
academic research
Slingshot Therapeutics
biotech

Pages